Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- ‘I only represent Jamaica’
- Daniel Farke gives fitness update ahead of Forest clash
- AMCH launches rare disease treatment, begins medicine distribution as Centre of Excellence
- How Brexit transformed the UK health care workforce
- 5 simple things that could potentially save your life, according to coroner
- The enjoyable exercise better than walking for lifelong fitness
- Officials warn firefighters about the risks of using a supplement for smoke exposure
- Summer baby boom at Lois Hole Hospital for Women in Edmonton
Browsing: Conditions
COVID-19 cases are rising in all 50 states, and doctors say some people remain at risk of serious illness
The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily reflect those of this site or affiliated companies
An outbreak of Legionnaires’ disease near the downtown core is under investigation by Toronto Public Health (TPH)
WASHINGTON (TNND) —Health and Human Services Secretary Robert F. Kennedy Jr. and actor Dennis Quaid teamed up Monday to make an announcement about furthering research about Lyme disease
August 17, 2026 ByLynne Christensen, Staff Writer
The post First Evidence a Vertebrate Survives Disease by Seeking Cold appeared first on A-Z Animals
A patient of record walks in for what should be a routine six-month adult prophylaxis visit. As part of the initial assessment, the dental hygienist takes the patient’s blood pressure: 180/110.
The leader of U.S. Central Command, Adm. Brad Cooper, wrote Sunday that his recent visit to the USS Abraham Lincoln was “awe-inspiring” and hailed the crew’s “resilience” following rising concerns about mental health and deteriorating conditions aboard the aircraft carrier
Johnson & Johnson has entered a collaboration and equity investment agreement with Sail Biomedicines, a Flagship Pioneering company, to advance in vivo CAR T-cell therapies for immune-mediated diseases. As part of the agreement, Johnson & Johnson secured an exclusive option to acquire Sail for $2.58 billion. The companies will jointly advance Sail's lead in vivo…
SHANGHAI & CAMBRIDGE, Mass. & AMSTERDAM–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and argenx (Euronext & NASDAQ: ARGX), today announced positive topline results from the ALKIVIA Phase 3 study evaluating VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with autoimmune myositis

